Leede Jones Gable analyst Douglas Loe provided an update on Wednesday on drug developer ProMIS Neurosciences (ProMIS Neurosciences Stock Quote, Charts, News, Analysts, Financials TSX:PMN), saying strong clinical results from a peer company working on Alzheimer’s disease are a positive for ProMIS. Japan-based Eisai Co announced on Wednesday that its Phase 3 Clarity AD 1,795-patient […]
Even with a shake-up at the helm, it’s still full steam ahead for Canadian biopharmaceutical company NervGen Pharma (NervGen Pharma Stock Quote, Charts, News, Analysts, Financials TSX:NGEN), according to Paradigm Capital analyst Scott McAuley, who in a recent client report reiterated a “Speculative Buy” rating on the stock due to its promise in the neurodegenerative […]
Share
Tweet
Share
